Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops and researches reagents for genome engineering and analysis, the technology used for gene therapy and natural health food products. The company's products include next generation sequencing, gene function, stem cell research, protein research products, PCR products, cloning products, nucleic acid purification, antibodies and ELISA, real time PCR products, mRNA and cDNA synthesis, COVID-19 research products, among others. The offers services single-cell analysis, instrument services, stem cell services, gene and cell therapy manufacturing. Takara is headquartered in Kusatsu, Shiga, Japan.
Headquarters
Japan
Address
7-4-38, Noji-Higashi, Kusatsu, Shiga, 525-0058
Website
www.takara-bio.co.jp
No of Employees
1,779
Industry
Medical Equipment
Revenue (2026)
$259.1M
Takara Bio Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Next-Generation Sequencing: | Single-cell Analysis | RetroNectin |
| RNA-Seq | Instrument Services | SiTCR |
| DNA-Seq | Stem Cell Services | CereAAV |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Others | In June, the company announced discussions with the Sumitomo Chemical Group to sell TBI-1301, a proprietary gene therapy clinical development project. |
| 2026 | Others | In June, the company announced discussions with Sumitomo Chemical Co., Ltd. and Sumitomo Pharma Co., Ltd. to sell its GMP-compliant cell processing contract manufacturing business, including its employees engaged in Business to S-RACMO Co., Ltd. |
| 2026 | Contracts/Agreements | In April, the company deepened its collaboration with Resistomap to scale high-throughput environmental antimicrobial‐resistance surveillance. |
Competitor Comparison
| Key Parameters | Takara Bio Inc | Biofermin Pharmaceutical Co Ltd | Kidswell Bio Corp | AnGes Inc | CellSeed Inc |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Kusatsu | Kobe | Chuo-Ku | Ibaraki | Koto-Ku |
| State/Province | Shiga | Hyogo | Tokyo | Osaka | Tokyo |
| No. of Employees | 1,779 | 155 | 37 | 56 | 36 |
| Entity Type | Private | Private | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Koichi Nakao | Chairman | Executive Board | - | - |
| Tsuyoshi Miyamura | Chief Executive Officer; Director; President | Executive Board | - | - |
| Katsuhiko Kusakabe | Director; Executive Officer; Vice President | Executive Board | - | - |
| Yoh Hamaoka | Director; Executive Officer; Vice President | Executive Board | - | - |
| Junichi Mineno | Director; Vice President; Executive Officer | Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer